|
|
Volumn 149, Issue 2, 2010, Pages 233-235
|
|
Matrix metalloproteinases 2, 7, 9 and tissue inhibitor of matrix metalloproteinase-1 in the sera of patients with bone tumors
a
|
|
Author keywords
bone tumors; MMP 2, 7, 9; serum; TIMP 1
|
|
Indexed keywords
GELATINASE A;
GELATINASE B;
MATRILYSIN;
TISSUE INHIBITOR OF METALLOPROTEINASE 1;
ADULT;
ARTICLE;
BONE TUMOR;
CANCER SURVIVAL;
CHONDROSARCOMA;
CLASSICAL CENTRAL OSTEOSARCOMA;
CONTROLLED STUDY;
CORRELATION ANALYSIS;
EWING SARCOMA;
FEMALE;
HUMAN;
IMMUNOASSAY;
MAJOR CLINICAL STUDY;
MALE;
MALIGNANT FIBROUS HISTIOCYTOMA;
OSTEOCLASTOMA;
OSTEOSARCOMA;
OVERALL SURVIVAL;
PERIOSTEAL OSTEOSARCOMA;
PROGNOSIS;
PROTEIN BLOOD LEVEL;
PROTEIN DETERMINATION;
PROTEIN EXPRESSION;
PROTEIN FUNCTION;
PROTEIN LOCALIZATION;
SURVIVAL TIME;
TUMOR LOCALIZATION;
TUMOR VOLUME;
ADOLESCENT;
ADULT;
BONE NEOPLASMS;
FEMALE;
HUMANS;
IMMUNOENZYME TECHNIQUES;
MALE;
MATRIX METALLOPROTEINASE 2;
MATRIX METALLOPROTEINASE 7;
MATRIX METALLOPROTEINASE 9;
MIDDLE AGED;
STATISTICS, NONPARAMETRIC;
SURVIVAL ANALYSIS;
TISSUE INHIBITOR OF METALLOPROTEINASE-1;
|
|
EID: 77956189078
PISSN: 00074888
EISSN: None
Source Type: Journal
DOI: 10.1007/s10517-010-0914-3 Document Type: Article |
|
Times cited : (16)
|
|
References (15)
|
